Ingrowth of aorta vascular cells into basic fibroblast growth factor-impregnated vascular prosthesis material: A porcine and human in vitro study on blood vessel prosthesis healing

Journal of Vascular Surgery

Volumn 36, Issue 6, 2002, Pages 1237-1247

  Van der Bas, J M Annemieke ^a,b   Quax, Paul H A ^a,b   Van den Berg, Arjen C ^a   Van Hinsbergh, Victor W M ^a   Van Bockel, J Hajo ^b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN; DACRON; HEPARIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; VASCULOTROPIN;

ANIMAL TISSUE; AORTA; AORTA ANEURYSM; AORTA GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL PROSTHESIS; CELL GROWTH; DACRON IMPLANT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROSTHESIS MATERIAL; SWINE; WOUND HEALING;

EID: 0037003503     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.128932     Document Type: Article

References (42)

1. Akkersdijk GJ, van der Graaf Y, Moll FL, de Vries AC, Kitslaar PJ, van Bockel JH, et al. Complications of standard elective abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 1998;15:505-10.
2. Scott RA. UK Small Aneurysms Trial. Lancet 1999;353:408.
3. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet 1998;352:1649-55.
4. Belkin M, Donaldson MC, Whittemore AD. Abdominal aortic aneurysms, Curr Opin Cardiol 1994;9:581-90.
5. Collin J. UK Small Aneurysms Trial. Lancet 1999;353:407-8.
6. de Virgilio C, Bui H, Donayre C, Ephraim L, Lewis RJ, Elbassir M, et al. Endovascular vs open abdominal aortic aneurysm repair: a comparison of cardiac morbidity and mortality. Arch Surg 1999;134:947-50.
7. Dorffner R, Thurnher S, Polterauer P, Kretschmer G, Lammer J. Treatment of abdominal aortic aneurysms with transfemoral placement of stent-grafts: complications and secondary radiologic intervention. Radiology 1997;204:79-86.
8. Moore WS, Kashyap VS, Vescera CL, Quinones-Baldrich WJ. Abdominal aortic aneurysm: a 6-year comparison of endovascular versus transabdominal repair. Ann Surg 1999;230:298-306.
9. Walker SR, Macierewicz J, MacSweeney ST, Gregson RH, Whitaker SC, Wenham PW, et al. Mortality rates following endovascular repair of abdominal aortic aneurysms. J Endovasc Surg 1999;6:233-8.
10. Zarins CK, White RA, Schwarten D, Kinney E, Diethrich EB, Hodgson KJ, et al. Aneurysms stent graft versus open surgical repair of abdominal aortic aneurysms: multicenter prospective clinical trial. J Vasc Surg 1999;29:292-305.
11. Chuter TA, Faruqi RM, Sawhney R, Reilly LM, Kerlan RB, Canto CJ, et al. Endoleak after endovascular repair of abdominal aortic aneurysm. J Vasc Surg 2001;34:98-105.
12. Schurink GW, Aarts NJ, Wilde J, Van Baalen JM, Chuter TA, Schultze Kool LJ, et al. Endoleakage after stent-graft treatment of abdominal aneurysm: implications on pressure and imaging: an in vitro study. J Vasc Surg 1998;28:234-41.
13. Schurink GW, Aarts NJ, Van Baalen JM, Chuter TA, Schultze KL, van Bockel JH. Late endoleak after endovascular therapy for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 1999;17:448-50.
14. White GH, Yu W, May J, Chaufour X, Stephen MS. Endoleak as a complication of endoluminal grafting of abdominal aortic aneurysms: classification, incidence, diagnosis, and management. J Endovasc Surg 1997;4:152-68.
15. Schurink GWH, Aarts NJ, Van Bockel JH. Endoleak after stent-graft treatment of abdominal aortic aneurysm: a meta-analysis of clinical studies. Br J Surg 1999;86:581-7.
16. Makaroun MS. The Ancure endografting system: an update. J Vasc Surg 2001;33(2 Pt 2):129-34.
17. Greenberg RK, Lawrence-Brown M, Bhandari G, Hartley D, Stelter W, Umscheid T, et al. An update of the Zenith endovascular graft for abdominal aortic aneurysms: initial implantation and mid-term follow-up data. J Vasc Surg 2001;33(2 Pt 2):157-64.
18. Vallabhaneni SR, Harris PL. Overview of the complications following endovascular AAA repair. In: Branchereau A, Jacobs M, editors. Complications in vascular and endovascular surgery. Part II. Armonk (NY): Futura Publishing; 2002. p. 129-36.
19. Guidoin R, Marois Y, Douville Y, King MW, Castonguay M, Traore A, et al. Analysis of explanted Stentor devices from the EUROSTAR Registry. J Endovasc Ther 2000;7:105-22.
20. Malina M, Brunkwall J, Ivancev K, Jonsson J, Malina J, Lindblad B. Endovascular healing is inadequate for fixation of Dacron stent-grafts in human aortoiliac vessels. Eur J Vase Endovasc Surg 2000;19:5-11.
21. Szilagyi DE. The problem of healing of endovascular stent grafts in the repair of abdominal aortic aneurysms. J Vase Surg 2001;33:1283-5.
22. Buth J. Endovascular repair of abdominal aortic aneurysms. Results from the EUROSTAR registry. EUROpean collaborators on Stentgraft Techniques for abdominal aortic Aneurysm Repair. Semin Interv Cardiol 2000;5:29-33.
23. Riepe G, Heilberger P, Umscheid T, Chakfe N, Raithel D, Stelter W, et al. Frame dislocation of body middle rings in endovascular stent tube grafts. Eur J Vase Endovasc Surg 1999;17:28-34.
24. Slomp J, Gittenberger-deGroot AC, van Munsteren JC, Huysmans HA, van Bockel JH, van Hinsbergh V, et al. Nature and origin of the neointima in whole vessel wall organ culture of the human saphenous vein. Virchows Arch 1996;428:59-67.
25. Soyombo AA, Angelini GD, Bryan AJ, Jasani B, Newby AC. Intimal proliferation in an organ Culture of human saphenous vein. Am J Pathol 1990;137:1401-10.
26. van Wachem PB, Plantinga JA, Wissink MJ, Beernink R, Poot AA, Engbers GH, et al. In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: effects of crosslink density, heparin immobilization, and bFGF loading. J Biomed Mater Res 2001;55:368-78.
27. Wissink MJ, van Luyn MJ, Beernink R, Poot AA, Engbers GH, Beugeling T, et al. Endothelial cell seeding on crosslinked collagen: effects of crosslinking on endothelial cell proliferation and functional parameters. Thromb Haemost 2000;84:325-31.
28. Wissink MJ, Beernink R, Poot AA, Engbers GH, Beugeling T, van Aken WG, et al. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release 2000;64:103-14.
29. Wissink MJ, Beernink R, Scharenborg NM, Poor AA, Engbers GH, Beugeling T, et al. Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors. J Control Release 2000;67:141-55.
30. Wissink MJ, Beernink R, Pieper JS, Poot AA, Engbers GH, Beugeling T, et al. Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials 2001;22:2291-9.
31. Wissink MJ, Beernink R, Pieper JS, Poor AA, Engbers GH, Beugeling T, et al. Immobilization ofheparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. Biomaterials 2001;22:151-63.
32. Kroon ME, Koolwijk P, van der Vecht B, van Hinsbergh VW J. Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways. Cell Sci 2001;114(Pt 4):825-33.
33. Ncgre-Aminou P, van Erck M, van Leeuwen RE, Collard JG, Cohen LH. Differential effect of simvastatin on various signal transduction intermediates in cultured human smooth muscle cells. Biochem Pharmacol 2001;15;61:991-8.
34. Holt CM, Francis SE, Rogers S, Gadsdon PA, Taylor T, Clelland C, et al. Intimal proliferation in an organ culture of human internal mammary artery. Cardiovasc Res 1992;26:1189-94.
35. Boyle JR, McDermott E, Crowther M, Wills AD, Bell PR, Thompson MM. Doxycycline inhibits elastin degradation and reduces mctalloproteinase activity in a model of aneurysmal disease. J Vase Surg 1998;27:354-61.
36. Koo EW, Gotlieb AI. Neointimal formation in the porcine aortic organ culture. I. Cellular dynamics over 1 month. Lab Invest 1991;64:743-53.
37. Sidawy AN, Mitchell ME, Neville RF. Pcptide growth factors and signal transduction. Semin Vasc Surg 1998;11:149-55.
38. Zalewski A, Shi Y. Vascular myofibroblasts. Lessons from coronary repair and remodeling. Arterioscler Thromb Vase Biol 1997;17:417-22.
39. Meister RH, Schweiger H, Lang W. Knitted double-velour Dacron prostheses in aortobifemoral position: long-term performance of different coating materials. Vasa 1998;27:236-9.
40. Noishiki Y, Ma XH, Yamane Y, Satoh S, Okoshi T, Takahashi K, et al. Succinylated collagen crosslinked by thermal treatment for coating vascular prostheses. Artif Organs 1998;22:672-80.
41. Wesolowski SA, Fries CC, Hennigar G, Fox LM, Sawyer PN, Sauvage LR. Factors contributing to long-term failures in human vascular prosthetic grafts. J Cardiovasc Surg (Torino) 1964;5:544-4.
42. Unger EF, Goncalves L, Epstein SE, Chew EY, Trapnell CB, Cannon RO, et al. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am J Cardiol 2000;85:1414-9.